The problem (forgetting the expense) is the short half-life of SS-31. We need something that does the same thing with a longer half-life. I hope someone is working on this.
The elimination half-life of subcutaneously (SC) injected SS-31 (elamipretide) in the human body is approximately 2 hours.
Key pharmacokinetic details for SC administration in humans include:
- Absorption: Peak plasma concentrations are typically reached within 0.5 to 1 hour after injection.
- Bioavailability: The absolute bioavailability of a subcutaneous dose is high, at approximately 92%.
- Distribution: It is distributed throughout total body water with a volume of distribution of roughly 0.5 L/kg and approximately 39% protein binding.
- Metabolism & Elimination: It undergoes sequential C-terminal degradation into inactive metabolites (M1 and M2). Roughly 100% of the dose and its metabolites are recovered in the urine within 48 hours in individuals with normal renal function.
- Accumulation: There is minimal accumulation of the parent drug with standard once-daily dosing.
Here is some prescription dosing information. Ref
